Circulate Health Announces Strategic Investment from Scrum Ventures
"We're entering a new era where more and more consumers are recognizing the benefits of TPE," said
Circulate Health's platform leverages advanced TPE technology designed to remove circulating microplastics, environmental toxins, inflammatory markers, and other microscopic pollutants. Early research suggests that these particles may accumulate over time, contributing to systemic inflammation, oxidative stress, and potential long-term health challenges.
"The shift toward proactive, science-backed longevity care is one of the most important movements in modern health," said
This partnership signals the convergence of two rapidly growing fields and will help further advance their respective industries in the coming months.
About Circulate Health
Backed by Khosla Ventures, Circulate Health is pioneering technologies to reverse aging and improve health outcomes. Learn more at https://www.circulate.health/.
About Scrum Ventures
Scrum Ventures is a seed-stage venture capital firm based in
View original content:https://www.prnewswire.com/news-releases/circulate-health-announces-strategic-investment-from-scrum-ventures-302629720.html
SOURCE Circulate Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO
- Himax WiseEye Palm Vein Biometric Authentication Technology Powers WAFERLOCK L322 Smart Lock
- Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share